id: alcohol_use_disorder_to_alcohol_induced_mortality
name: Alcohol Use Disorder â†’ Alcohol-Induced Mortality
from_node:
  node_id: alcohol_use_disorder
  node_name: Alcohol Use Disorder
to_node:
  node_id: alcohol_induced_mortality
  node_name: Alcohol-Induced Mortality
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: Diagnosed AUD is associated with continued heavy alcohol consumption and difficulty achieving
  sustained abstinence'
- 'Step 2: Chronic alcohol exposure leads to progressive hepatic fibrosis, cirrhosis, and hepatocellular
  carcinoma'
- 'Step 3: Cardiovascular complications including alcoholic cardiomyopathy and arrhythmias develop'
- 'Step 4: Neurological degeneration and increased risk of severe withdrawal complications including delirium
  tremens'
- 'Step 5: Multi-organ damage results in elevated mortality rate among AUD patients'
evidence:
  quality_rating: B
  n_studies: 3
  primary_citation: 'Tessa Carr et al. 2024. "The risk relationships between alcohol consumption, alcohol
    use disorder and alcohol use disorder mortality: A systematic review and meta-analysis.." https://doi.org/10.1111/add.16456'
  supporting_citations:
  - Studies meeting inclusion criteria for mortality rates in AUD patients
  - Additional citations require full-text access
  doi: 10.1111/add.16456
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: Patients diagnosed with alcohol use disorder have an elevated mortality rate of 3.13 per
  1000 person-years. This reflects the considerable health burden associated with AUD, including direct
  alcohol toxicity and related chronic diseases.
quantitative_effects:
  effect_size:
    value: 3.13
    type: relative_risk
    ci_lower: 1.07
    ci_upper: 9.13
structural_competency:
  equity_implications: AUD mortality is influenced by structural factors including treatment availability,
    healthcare access, insurance coverage for substance use disorders, stigma in healthcare settings,
    and social determinants affecting recovery support. Medication-assisted treatment and evidence-based
    psychosocial interventions can reduce mortality but remain underutilized due to system-level barriers.
    Structural racism and economic inequality create differential access to quality treatment.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:36.281401'
  extraction_confidence: medium
  prompt_version: 2.1-canonical-validated
